関連する実験動画
Updated: Feb 28, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
現在の肥満治療における治療意思決定と減量期待
Sujaytha Paknikar1, Meera Shah2
1Mayo Clinic Division of Endocrinology 1, RO_MA_18_03E-EN Mayo Building 200 1st St SW, Rochester, MN, 55905, USA.
Current obesity reports
|February 27, 2026
まとめ
肥満治療には共同意思決定の枠組みが不可欠である。本レビューは、効果的な肥満管理のための患者と提供者の選択に影響を与える要因を探り、個別化ケアを目指す。
背景:
- 肥満は、慢性的な医学的状態として分類される、増大する世界的な健康危機である。
- 現在の肥満治療には、ライフスタイル介入、薬物療法、および肥満手術が含まれる。
- 新興の医学的治療法は、肥満手術に匹敵する有効性を示すが、利用と選択において課題に直面している。
研究 の 目的:
- 肥満治療における共同意思決定の枠組みを確立する。
- 肥満の治療選択に影響を与える要因を分析する。
- 個別化された肥満管理戦略を導く。
主な方法:
- 本レビューは、肥満治療法に関する現在の文献を統合する。
- 患者と提供者の視点、および行動的、生物学的、社会経済的決定要因を検討する。
- 分析は、共同意思決定を通じた治療選択の最適化に焦点を当てる。
主要な成果:
- インクレチンベースの治療法は、肥満管理において有意な有効性を提供する。
- 過小評価と最適でない治療選択が、主要な課題として残っている。
- 患者/提供者の期待と多様な患者要因が、治療決定に критически 影響を与える。
結論:
- 肥満治療への個別化されたアプローチが不可欠である。
- 共同意思決定は、治療アドヒアランスと転帰を改善できる。
- 将来の研究は、調整された肥満ケアのための遺伝的および表現型の特徴付けに焦点を当てるべきである。
関連する概念動画
Drug Dosing: Obese Patients
315
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
315
Diabetes: Management and Pharmacotherapy
1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
324
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
250
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
250
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Role of Communication in the Nursing Process II: Planning and Implementation
2.8K
Several factors are considered while creating a patient's care plan. Motivation is a factor in improving communication, and patients often require encouragement to try different approaches involving significant change. It is essential to involve the patient and family in decisions about the plan of care to determine whether the suggested methods are acceptable. Consider meeting critical comfort and safety needs before introducing new communication methods and techniques. Allow adequate time...
2.8K

